Filing Details

Accession Number:
0000921895-22-002282
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-07-25 16:46:21
Reporting Period:
2022-07-21
Accepted Time:
2022-07-25 16:46:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1651561 Tabula Rasa Healthcare Inc. TRHC () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1250078 C Derek Schrier C/O Indaba Capital Management, L.p.
One Letterman Dr., Blding D, Suite Dm700
San Francisco CA 94129
No No Yes No
1524362 Indaba Capital Management, L.p. One Letterman Drive
Building D, Suite Dm700
San Francisco CA 94129
No No Yes No
1596505 Ic Gp, Llc One Letterman Drive,
Building D, Suite Dm700
San Francisco CA 94129
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-07-21 179,790 $3.80 5,348,814 No 4 P Indirect See Footnotes
Common Stock Acquisiton 2022-07-21 180,210 $3.97 5,529,024 No 4 P Indirect See Footnotes
Common Stock Acquisiton 2022-07-21 250,000 $3.58 5,779,024 No 4 P Indirect See Footnotes
Common Stock Acquisiton 2022-07-21 290,000 $4.11 6,069,024 No 4 P Indirect See Footnotes
Common Stock Acquisiton 2022-07-21 100,000 $4.15 6,169,024 No 4 P Indirect See Footnotes
Common Stock Acquisiton 2022-07-22 100,000 $4.22 6,269,024 No 4 P Indirect See Footnotes
Common Stock Acquisiton 2022-07-22 103,292 $4.06 6,372,316 No 4 P Indirect See Footnotes
Common Stock Acquisiton 2022-07-22 90,000 $4.43 6,462,316 No 4 P Indirect See Footnotes
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See Footnotes
No 4 P Indirect See Footnotes
No 4 P Indirect See Footnotes
No 4 P Indirect See Footnotes
No 4 P Indirect See Footnotes
No 4 P Indirect See Footnotes
No 4 P Indirect See Footnotes
No 4 P Indirect See Footnotes
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock 1.75% Convertible Senior Subordinated Notes due 2026 $0.00 2026-02-15 1,282,805 1,282,805 Indirect
Expiration Date Amount Remaning Holdings Nature of Ownership
2026-02-15 1,282,805 1,282,805 Indirect
Footnotes
  1. This Form 4 is filed jointly by Indaba Capital Management, L.P. (the "Investment Manager"), IC GP, LLC ("IC GP"), and Derek C. Schrier (collectively, the "Reporting Persons"). Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.
  2. Securities are held directly by Indaba Capital Fund, L.P. (the "Fund"). Pursuant to an Investment Management Agreement, the Fund and its general partner have delegated all voting and investment power over the securities directly held by the Fund to the Investment Manager. As a result, each of the Investment Manager, IC GP, as the general partner of Investment Manager, and Mr. Schrier, as Managing Member of IC GP, may be deemed to exercise voting and investment power over such securities. The Fund specifically disclaims beneficial ownership of such securities by virtue of its inability to vote or dispose of such securities as a result of such delegation to the Investment Manager.
  3. The Fund directly holds $89,728,000 principal amount of the Issuer's 1.75% Convertible Senior Subordinated Notes due February 15, 2026 (the "Senior Notes"). Subject to conditions described in the indenture governing the Senior Notes, holders of the Senior Notes have the right to convert all or any portion of such Senior Notes into shares of the Issuer's Common Stock at an initial conversion rate of 14.2966 shares of Common Stock per $1,000 principal amount of Senior Notes, subject to adjustment as described in the indenture.
  4. As the Issuer has the option, at its sole discretion, to settle conversions of the Senior Notes in cash, shares of Common Stock or a combination of cash and shares of Common Stock, the Reporting Persons are not deemed to be beneficial owners of any shares of Common Stock underlying the Senior Notes for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, as the Reporting Persons do not have the right to acquire such underlying shares of Common Stock.